Treatment of superficial infantile hemangiomas with timolol: Evaluation of short-term efficacy and safety in infants
Authors:
Open Access
- 21 June 2013
- journal article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 6 (2) , 388-390
Abstract
Timolol has been demonstrated to be efficacious in the topical treatment of superficial infantile hemangiomas (IHs). We conducted a prospective study to evaluate the short-term efficacy and safety of timolol in the treatment of superficial IH in Chinese infants. From March to November 2012, 124 patients with superficial IHs were included in the prospective study. The patients were divided into two groups: treatment (101 patients, the timolol drops were administered on the surface of the lesions three times daily, and erythromycin ointment was applied around the lesions) and observation (23 patients, without treatment). The results were categorized into three grades: class 1 (ineffective), class 2 (controlled growth) and class 3 (promoted regression). Within one week of the initiation of timolol treatment, a number of the lesions became softer and lighter in color. Four months following the initiation of timolol treatment, the overall response was class 1 in eight patients (7.9%), class 2 in 36 patients (35.6%) and class 3 in 57 patients (56.4%). Complete tumor regression was observed in 12 patients. No adverse effects were recorded during the treatment period. Among the patients in the observation group, there were 15 class 1 patients (65.2%), seven class 2 patients (30.4%) and only one class 3 patient (4.3%). In conclusion, timolol is an effective and safe treatment for superficial IH. In addition, it may be used in the treatment of proliferative superficial IH, particularly in infants within 6 months of age.Keywords
This publication has 10 references indexed in Scilit:
- Management of vascular malformations and hemangiomas of the head and neck - an updateCurrent Opinion in Otolaryngology & Head and Neck Surgery, 2013
- Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective studyClinical and Experimental Dermatology, 2012
- [Topical timolol in the treatment of periocular superficial infantile hemangiomas: a prospective study].2012
- A Controlled Study of Topical 0.25% Timolol Maleate Gel for the Treatment of Cutaneous Infantile Capillary HemangiomasOphthalmic Plastic & Reconstructive Surgery, 2012
- Abortive segmental perineal hemangiomaDermatology Online Journal, 2011
- Topical Timolol for Periocular Hemangioma: Report of Further StudyArchives of Ophthalmology (1950), 2011
- Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndromeBritish Journal of Dermatology, 2010
- Topical Timolol Gel for Infantile Hemangiomas: A Pilot StudyArchives of Dermatology, 2010
- Topical Treatment for Capillary Hemangioma of the Eyelid Using β-Blocker SolutionArchives of Ophthalmology (1950), 2010
- Hypoxia, Hormones, and Endothelial Progenitor Cells in HemangiomaLymphatic Research and Biology, 2007